MELK is not necessary for the proliferation of basal-like breast cancer cells
Hai‐Tsang Huang(Boston University), Nathanael S. Gray(Stanford University), Behnam Nabet(University of Washington), Hilary McLauchlan(University of Dundee), Sirano Dhe‐Paganon(Neuroendocrine Tumor Research Foundation), Michael J. Eck(Harvard University), Justin M. Roberts(Dana-Farber Cancer Institute), Jean J. Zhao(Harvard University), Baishan Jiang(Wuhan University), Jennifer L. Moran(Broad Institute), Shiva Dastjerdi(Dana-Farber Cancer Institute), Hyuk‐Soo Seo(Dana-Farber Cancer Institute), Dennis L. Buckley(Dana-Farber Cancer Institute), Qing Li(Jinzhou Medical University), Yubao Wang(Albert Einstein College of Medicine), Tinghu Zhang(Harvard University), Georg E. Winter(Austrian Academy of Sciences), James E. Bradner(Harvard University), Joshiawa Paulk(Dana-Farber Cancer Institute)
Cited by 194
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Biological insights from 108 schizophrenia-associated genetic loci
|Nature|2014|8.1k
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k